openPR Logo
Press release

Zollinger-Ellison Syndrome Treatment Market (2024-2032): Strategic Insights into Growth Drivers, and Competitive Strategies | Pfizer Inc., Novartis AG, AstraZeneca plc

10-08-2024 09:51 AM CET | Health & Medicine

Press release from: Polaris Market Research & Consulting

Zollinger-Ellison Syndrome Treatment Market

Zollinger-Ellison Syndrome Treatment Market

๐“๐ก๐ž ๐ ๐ฅ๐จ๐›๐š๐ฅ ๐™๐จ๐ฅ๐ฅ๐ข๐ง๐ ๐ž๐ซ-๐„๐ฅ๐ฅ๐ข๐ฌ๐จ๐ง ๐ฌ๐ฒ๐ง๐๐ซ๐จ๐ฆ๐ž ๐ญ๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ฌ ๐ž๐ฑ๐ฉ๐ž๐œ๐ญ๐ž๐ ๐ญ๐จ ๐ซ๐ž๐š๐œ๐ก ๐”๐’๐ƒ ๐Ÿ,๐Ÿ—๐Ÿ–๐Ÿ–.๐Ÿ๐Ÿ‘ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐›๐ฒ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ, ๐ ๐ซ๐จ๐ฐ๐ข๐ง๐  ๐š๐ญ ๐š ๐Ÿ’.๐Ÿ’% ๐‚๐€๐†๐‘ ๐Ÿ๐ซ๐จ๐ฆ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ’ ๐ญ๐จ ๐Ÿ๐ŸŽ๐Ÿ‘๐Ÿ. ๐ˆ๐ญ ๐ฐ๐š๐ฌ ๐ฏ๐š๐ฅ๐ฎ๐ž๐ ๐š๐ญ ๐”๐’๐ƒ ๐Ÿ,๐Ÿ‘๐Ÿ’๐Ÿ”.๐ŸŽ๐Ÿ“ ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ข๐ง ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ‘. The market is experiencing significant growth and is expected to continue expanding in the coming years.

Zollinger-Ellison syndrome is an occasional condition in which one or more tumors enlarge in the pancreas or the top part of the small intestine. The tumors are known as gastrinomas. Treatment of Zollinger-Ellison syndrome concentrates on curing the hormone-producing tumors and the ulcers they generate. An operation to extract gastrinomas needs an expert surgeon, as the tumors are frequently compact and arduous to detect. If there is just one tumor, the donor might be able to separate it surgically. However, surgery may not be an alternative if one has several tumors that have proliferated to the liver. Alternatively, even if one has optional tumors, the surgeon yet might approve extracting a solitary big tumor.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:
https://www.polarismarketresearch.com/industry-analysis/zollinger-ellison-syndrome-treatment-market/request-for-sample

๐‚๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐จ๐ง ๐‚๐š๐ญ๐ž๐ ๐จ๐ซ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง
The market involves several critical players who are diligently involved in advancing and offering treatment for this unique condition.
Key companies in the Zollinger-Ellison syndrome treatment market are mentioned below:
โ€ข Pfizer Inc.
โ€ข Takeda Pharmaceutical Company Limited
โ€ข Novartis AG
โ€ข Boehringer Ingelheim International GmbH
โ€ข AstraZeneca plc
โ€ข GlaxoSmithKline plc
โ€ข Eli Lilly and Company
โ€ข Sanofi S.A.
โ€ข AbbVie Inc.
โ€ข Merck & Co., Inc.
โ€ข Teva Pharmaceutical Industries Ltd.
โ€ข Sun Pharmaceutical Industries Ltd.
โ€ข Mylan N.V. (part of Viatris)
โ€ข Hoffmann-La Roche Ltd.
โ€ข Bristol-Myers Squibb Company

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ
โ€ข The demand for Zollinger-Ellison syndrome treatment is rising quickly due to premature and precise diagnoses crucial for handling ZES, as detained treatment can cause several obstacles. Inventions, such as enhanced imaging strategies involving endoscopic ultrasound (EUS) and somatostatin receptor scintigraphy (SRS), have notably improved the capacity to locate gastrinomas at premature stages.
โ€ข The Zollinger-Ellison syndrome treatment market demand is further increased by healthcare specialists and patients tendering earmarked therapies for handling detrimental illnesses. In some cases, conventional treatments are displaced by earmarked therapies as they target to confront the genesis of the syndrome, such as regulating gastric-generating tumors.
โ€ข North America dominated the market with the largest share.
โ€ข Europe is expected to grow at the quickest rate during the forecast period.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐š ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐๐ž๐Ÿ๐จ๐ซ๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž:
https://www.polarismarketresearch.com/industry-analysis/zollinger-ellison-syndrome-treatment-market/request-for-discount-pricing

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ฅ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
๐๐ฒ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Chemotherapy
โ€ข Surgical Resection
โ€ข Others

๐๐ฒ ๐ƒ๐ข๐š๐ ๐ง๐จ๐ฌ๐ข๐ฌ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Blood Test
โ€ข CT scan Ultrasound
โ€ข X-Ray
โ€ข Others

๐๐ฒ ๐„๐ง๐ ๐”๐ฌ๐ž๐ซ๐ฌ ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค
โ€ข Hospitals
โ€ข Specialty Clinics
โ€ข Others

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐“๐ก๐ž ๐‚๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž ๐‚๐จ๐ฆ๐ฉ๐ซ๐ž๐ก๐ž๐ง๐ฌ๐ข๐ฏ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐‡๐ž๐ซ๐ž:
https://www.polarismarketresearch.com/industry-analysis/zollinger-ellison-syndrome-treatment-market

๐…๐€๐'๐’
1. How much is the global Zollinger-Ellison syndrome treatment market?
The global Zollinger-Ellison syndrome treatment market size was valued at USD 1,346.05 million in 2023 and is projected to grow to USD 1,988.13 million by 2032.

2. What is the global Zollinger-Ellison syndrome treatment market growth rate?
The global market is projected to register a CAGR of 4.4% during 2024-2032.

3. Which region held the largest share of the global market?
North America accounted for the largest share of the global market in 2023.

๐Œ๐จ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ข๐ง๐  ๐‹๐š๐ญ๐ž๐ฌ๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐›๐ฒ ๐๐จ๐ฅ๐š๐ซ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:
๐“๐ซ๐š๐ง๐ฌ๐ญ๐ก๐ฒ๐ซ๐ž๐ญ๐ข๐ง ๐€๐ฆ๐ฒ๐ฅ๐จ๐ข๐๐จ๐ฌ๐ข๐ฌ ๐“๐ซ๐ž๐š๐ญ๐ฆ๐ž๐ง๐ญ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/transthyretin-amyloidosis-treatment-market

๐Œ๐ž๐๐ข๐œ๐š๐ฅ ๐“๐ž๐ซ๐ฆ๐ข๐ง๐จ๐ฅ๐จ๐ ๐ฒ ๐’๐จ๐Ÿ๐ญ๐ฐ๐š๐ซ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/medical-terminology-software-market

๐ƒ๐ข๐ ๐ข๐ญ๐š๐ฅ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/digital-pharmacy-market

๐‚๐จ๐ฅ๐ ๐๐š๐ข๐ง ๐“๐ก๐ž๐ซ๐š๐ฉ๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/cold-pain-therapy-market

๐„๐ง๐๐จ๐ฅ๐ฎ๐ฆ๐ข๐ง๐š๐ฅ ๐’๐ฎ๐ญ๐ฎ๐ซ๐ข๐ง๐  ๐ƒ๐ž๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ
https://www.polarismarketresearch.com/industry-analysis/endoluminal-suturing-devices-market

Contact:
Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Zollinger-Ellison Syndrome Treatment Market (2024-2032): Strategic Insights into Growth Drivers, and Competitive Strategies | Pfizer Inc., Novartis AG, AstraZeneca plc here

News-ID: 3681679 • Views: โ€ฆ

More Releases from Polaris Market Research & Consulting

US Surgical Dressings Market is projected to grow to USD 2,530.29 Million by 2034 to Register a CAGR of 4.9% During 2025-2034
US Surgical Dressings Market is projected to grow to USD 2,530.29 Million by 203 โ€ฆ
The US surgical dressings market report by Polaris Market Research offers an in-depth comprehension of the rapidly evolving sector. It examines all the key market aspects, including market share, size, trends, and recent developments. In addition, segmental analysis and competitive landscape have been provided to help stakeholders make informed decisions. The report analyzes the market for surgical dressings in the US to register a CAGR of 4.9% during 2025-2034. Theโ€ฆ
Prostate Cancer Biomarker Market Poised to Reach US$ 15.68 Billion Expanding at a 13.00% CAGR from 2025 to 2034
Prostate Cancer Biomarker Market Poised to Reach US$ 15.68 Billion Expanding at โ€ฆ
The global prostate cancer biomarker market is projected to a compound annual growth rate (CAGR) of 13.00% from 2025 to 2034. The market was valued at USD 4.60 billion in 2024 and is projected to grow to USD 15.58 billion by 2034. Market Introduction: Biomarkers are substances that can be detected in the body to provide information about a disease. Prostate cancer biomarkers are measurable substances, such as proteins, genes, orโ€ฆ
Formulation Development Outsourcing Market Forecasted to Hit USD 83.55 Billion by 2034, Growing at a CAGR of 8.4%
Formulation Development Outsourcing Market Forecasted to Hit USD 83.55 Billion b โ€ฆ
Polaris Market Research announces the release of its latest research report titled, "Formulation Development Outsourcing Market Size, Share, & Industry Analysis Report: By Formulation, By Service (Preformulation and Formulation Development), By Therapeutic Area, By End Use, and By Region - Market Forecast, 2025-2034." The report analyzes the market for formulation development outsourcing to register a CAGR of 8.4% during 2025-2034. The market was valued at USD 37.23 billion in 2024 andโ€ฆ
Endobronchial Ultrasound Biopsy Market Projected to Reach USD 1,150.11 Million by 2034, Expanding at a CAGR of 4.6%
Endobronchial Ultrasound Biopsy Market Projected to Reach USD 1,150.11 Million b โ€ฆ
Polaris Market Research announces the release of its latest research report titled, "Endobronchial Ultrasound Biopsy Market Size, Share, & Industry Analysis Report: By Product, By Procedure, By End Use (Hospitals, ASCs, and Specialty Clinics), and By Region - Market Forecast, 2025-2034." The report analyzes the market for endobronchial ultrasound biopsy to register a CAGR of 4.6% during the forecast period. The market was valued at USD 733.19 million in 2024 andโ€ฆ

All 5 Releases


More Releases for Treatment

Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea โ€ฆ
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 toโ€ฆ
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,โ€ฆ
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, โ€ฆ
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,โ€ฆ
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti โ€ฆ
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in anyโ€ฆ
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr โ€ฆ
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose ofโ€ฆ
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M โ€ฆ
Transparency Market Research (TMR) has published a new report titled โ€œAddiction Treatment Market โ€“ Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017โ€“2025โ€. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smokingโ€ฆ